Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
基本信息
- 批准号:10533304
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAmplifiersAutoimmunityBiochemicalBiologyCHEK1 geneCellsChromatinComplexCuesDNADNA DamageDNA Polymerase IIDNA TopoisomerasesDedicationsDependenceDiseaseEnvironmental Risk FactorEpigenetic ProcessEventGene ExpressionGenesGenetic TranscriptionGenomeGoalsHistone CodeHistone H3Histone H3.3HistonesHumanImmuneImmunityInflammationInflammatoryInflammatory ResponseKnowledgeLinkMacrophageMediatingMemoryMolecularMutationOncogenicOrganismPaperPathway interactionsPhosphorylationPolymerasePositioning AttributePost-Translational Protein ProcessingProteinsRoleSerineSignal PathwaySignal TransductionSiteSpecificitySpeedTailTherapeuticTimeTissuesTopoisomeraseTrainingTranscription CoactivatorVariantYeastsactivating transcription factor 1cell typeepigenetic regulationepigenomicsexperimental studyextracellulargene inductionin vivoinsightmetermutant mouse modelnovelpathogenprotein H(3)recruitresponsetherapeutic targettranscription factortransmission processtumorupstream kinase
项目摘要
Project Summary
Complex organisms are able to rapidly induce select genes among thousands in response to diverse
environmental cues. This occurs in the context of large genomes condensed with histone proteins into
chromatin. The macrophage response to pathogen sensing, for example, rapidly engages highly conserved
signaling pathways and transcription factors (TFs) for coordination of inflammatory gene induction. Enriched
integration of histone H3.3, the ancestral histone H3 variant, is a feature of inflammatory genes and, in general,
dynamically regulated chromatin and transcription. The amino-terminal H3.3 `tail' differs from the other H3
proteins by a single amino acid, a serine at position 31. However, little is known of how (or which) features of
H3.3, conserved from yeast to human, might enable rapid and high-level transcription. We have recently
discovered a potent function for H3.3-specific histone phosphorylation (H3.3S31ph) in inflammatory gene
transcription and surprising evidence that non-canonical activity of the DNA-damage response (DDR) pathway
mediates this histone phosphorylation. Thus, we hypothesize that the DDR pathway is coopted for epigenetic
regulation of inflammatory genes. In Aim 1 we will identify the factors and sequence of events that link DDR
factors and H3.3S31ph to rapid inflammatory gene transcription and reveal the function of cross-talk between
DDR and chromatin (H3.3S31ph) by employing novel histone mutant mouse models. Specifically, our
experiments will enable us to distinguish between several candidate “paths” to H3.3S31ph and amplification of
transcription, including Topoisomerase dependency, and DNA break-dependent and -independent pathways.
In Aim 2 we will identify how DDR-mediated H3.3S31ph uniquely regulates Pol II dynamics at select
inflammatory genes to amplify their transcription. More generally, these studies will identify dedicated
mechanisms that enable inflammatory gene induction with important implications for understanding
inflammation and for informing more selective therapeutic strategies for diverse inflammatory diseases.
项目摘要
复杂的生物体能够从数千个基因中快速诱导出精选基因,以响应不同的
环境线索。这发生在大基因组与组蛋白浓缩成
染色质。例如,巨噬细胞对病原体感应的反应迅速地与高度保守的
协调炎症基因诱导的信号通路和转录因子。丰富
整合组蛋白H3.3,祖先的组蛋白H3变体,是炎症基因的一个特征,通常,
动态调节染色质和转录。氨基末端H3.3‘Tail’与其他H3不同
蛋白质由单一氨基酸组成,第31位是丝氨酸。然而,对如何(或哪些)功能知之甚少
H3.3在酵母和人类之间保守,可能使快速和高水平转录成为可能。我们最近做了
在炎症基因中发现H3.3特异性组蛋白磷酸化(H3.3S31ph)的有效功能
转录和令人惊讶的证据表明DNA损伤反应(DDR)途径的非规范活性
介导组蛋白的磷酸化。因此,我们假设DDR途径被用于表观遗传
炎症基因的调控。在目标1中,我们将确定将复员方案联系起来的因素和事件顺序
因子和H3.3S31ph对快速炎症基因转录和揭示串扰功能之间的影响
DDR和染色质(H3.3S31ph)通过使用新的组蛋白突变小鼠模型。具体地说,我们的
实验将使我们能够区分几条通往H3.3S31ph的候选“路径”和放大
转录,包括拓扑异构酶依赖,以及DNA断裂依赖和非依赖途径。
在目标2中,我们将确定DDR介导的H3.3S31ph如何在SELECT中独特地调节POL II动态
炎性基因来放大它们的转录。更广泛地说,这些研究将确定专门的
致炎基因诱导的机制及其对理解的重要意义
为各种炎症性疾病提供更多有选择性的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Zvi Josefowicz其他文献
Steven Zvi Josefowicz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Zvi Josefowicz', 18)}}的其他基金
Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
- 批准号:
10321812 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
- 批准号:
10265789 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
- 批准号:
10305601 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
- 批准号:
10667676 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
- 批准号:
10736896 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Cooption of the DNA Damage Response For Epigenetic Regulation of Inflammation
炎症表观遗传调控的 DNA 损伤反应的共同选择
- 批准号:
10062828 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of Chromatin by Histone Phosphorylation
组蛋白磷酸化对染色质的调节
- 批准号:
9526129 - 财政年份:2015
- 资助金额:
$ 42.38万 - 项目类别:
Writing and Interpreting the Chromatin Enhancer Code in Myeloid Cells
写入和解释骨髓细胞中的染色质增强子代码
- 批准号:
8686006 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
Writing and Interpreting the Chromatin Enhancer Code in Myeloid Cells
写入和解释骨髓细胞中的染色质增强子代码
- 批准号:
8256242 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
Writing and Interpreting the Chromatin Enhancer Code in Myeloid Cells
写入和解释骨髓细胞中的染色质增强子代码
- 批准号:
8433586 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
相似海外基金
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Cooperative Agreement
Interferometric and Multiband optical Parametric Amplifiers for Communications (IMPAC)
用于通信的干涉式和多频带光学参量放大器 (IMPAC)
- 批准号:
EP/X031918/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Fellowship
Josephson Parametric Amplifiers using CVD graphene junctions
使用 CVD 石墨烯结的约瑟夫森参量放大器
- 批准号:
EP/Y003152/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Research Grant
Semiconductor-based Terahertz Traveling Wave Amplifiers for Monolithic Integration
用于单片集成的半导体太赫兹行波放大器
- 批准号:
2329940 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Standard Grant
OPTIME-PA: Optimal MMIC Design of E-Band Power Amplifiers for Satcom using Dedicated Measurements and Non-Linear Modelling
OPTIME-PA:使用专用测量和非线性建模的卫星通信 E 频段功率放大器的最佳 MMIC 设计
- 批准号:
10075892 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Collaborative R&D
Optical Glass Amplifiers for High Capacity Networks
用于高容量网络的光学玻璃放大器
- 批准号:
538379-2018 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Collaborative Research and Development Grants
Investigating the function of ZU5 domain-containing proteins as amplifiers of caspase activation
研究含有 ZU5 结构域的蛋白质作为 caspase 激活放大器的功能
- 批准号:
10681326 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Investigating the function of ZU5 domain-containing proteins as amplifiers of caspase activation
研究含有 ZU5 结构域的蛋白质作为 caspase 激活放大器的功能
- 批准号:
10621402 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Broadband Digital Doherty Amplifiers for Sub-6 GHz 5G wireless Applications
适用于 6 GHz 以下 5G 无线应用的宽带数字 Doherty 放大器
- 批准号:
573452-2022 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Alliance Grants
TALENT – Tapered AmpLifiErs for quaNtum Technologies
人才 — 量子技术的锥形放大器
- 批准号:
10032436 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Collaborative R&D














{{item.name}}会员




